Article Text

Download PDFPDF

VII European Paediatric Rheumatology Congress: Annual Scientific Meeting of PRES
  1. MICHAËL HOFER, Conference chairman

    Statistics from

    23–27 September 2000, Geneva, Switzerland

    Organised by:
    Swiss Working Group for Paediatric Rheumatology Centre Multisite Romand de Rhumatologie Pédiatrique
    Under the Patronage of:
    Swiss Society of Paediatry Swiss Society of Rheumatology

    Scientific counselling provided by the International Scientific Advisory Board, chaired by Patricia Woo, President of PRES  Honorary President: Anne-Marie Prieur, Paris

    Dear future members of PRES, friends, and colleagues The Paediatric Rheumatology European Society (PRES) was conceived in 1997 in Garmisch and was officially founded last year in Glasgow. The VIIth European Paediatric Rheumatology Congress will be the first annual meeting of our society. It will be a special pleasure for us to welcome you in Geneva in September 2000.

    “From pathogenesis to therapy in paediatric rheumatology: a challenge for the new decade” is the title of our scientific event. As we learnt in Glasgow, the long term outcome of paediatric rheumatic diseases may be accompanied by physical as well as social disabilities in a significant proportion of our patients, certainly many more than we had previously thought. Our common aim is to improve outcome, hence the need to work together to increase our knowledge, to learn from each other, and to have the opportunity to discuss important clinical issues. This is the aim of our new society and its annual meetings.

    This congress, at the turn of the decade, will be a good occasion to assess what stage pathogenesis and treatment of the disease has reached. Our hope is that the coming decade will bring us new insights into the pathogenesis of paediatric rheumatic diseases and that the promised new treatments will significantly improve the outcome of our patients. We expect that by 2010, the work of the participants of this congress, the members of PRES, and other scientists will have made significant advances. We set ourselves this challenge for the new decade, not only for the new century or new millennium.

    This congress will offer you state-of-the-art lectures on the pathogenesis of rheumatic diseases and future treatments, sessions on juvenile dermatomyositis, scleroderma, osteoporosis, and growth retardation. We will have two forums: one in which young investigators will present and discuss their continuing research; the second in which clinical data on the new classification of juvenile arthritis will be discussed.

    We await your scientific contribution, which could be presented either during the sessions or as a poster. This meeting will be a success only if you come with your scientific work, your experience, or your special case reports to share with your colleagues.

    On 25 and the 26 September the allied health professionals and social leagues will have their own sessions. The discussions will focus on two different concepts of physiotherapy and quality of life. On the last day will be the joint course for paediatric rheumatology sponsored by both the Swiss Society of Paediatry and the Swiss Society of Rheumatology.

    Geneva and Switzerland are happy to welcome you to the VIIth European Paediatric Rheumatology Congress. Besides science, we are sure you will enjoy our beautiful city and our cheerful country. After the heat of the summer, September is a lovely month to discover our mountains, lakes, and historical cities. We are looking forward to seeing you in Geneva from 23 to 27 September 2000.

    On behalf of the national organising committee:

    View Abstract

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.